International Science and Technology University

International Science and Technology University (ISTU) is a specialized biotechnology entity focused on the intersection of academic research and commercial drug development. The company leverages its proprietary Advanced Molecular Synthesis and Screening Platform to identify novel small molecule candidates and biologics for high-unmet-need areas in oncology and immunology. ISTU operates as a hybrid research-commercial organization, facilitating the translation of early-stage scientific discoveries into clinical-ready therapeutic programs. Its current pipeline includes several pre-clinical assets targeting validated pathways such as EGFR and PD-1, alongside novel vaccine candidates for emerging infectious diseases.